Rhythm Pharmaceuticals Inc. Live Stock Price Today, Share Analysis and Chart

Name: Rhythm Pharmaceuticals Inc.: Is Infosys Ltd. worth buying?
Item: Rhythm Pharmaceuticals Inc.
Rating: 1.674111125
Author: Trendlyne DVM scores

Momentum Trap

about

Rhythm Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. It is engaged in the development and commercialization of therapies for patients with rare diseases. The company is focused on its melanocortin-4 receptor (MC4R) agonists, in...

102.60 -1.63 (-1.56%)

New 52W High in past week

101.5K

XNAS Volume

XNAS 29 Aug, 2025 12:08 PM (EDT)

Low Financial Strength

27.8 / 100

Expensive Valuation

3.8 / 100

Technically Bullish

74.5 / 100

Momentum Trap These stocks are with a bad quality and poor financial score ranging from medium to expensive valuation. Rising technical aspects may attract investors, but, weak financials cannot be overlooked. View Similar Embed DVM

113

1Yr Price target upside is 10%

14 analysts

Rhythm Pharmaceuticals Inc. Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Rhythm Pharmaceuticals Inc. Live Stock Price Today, Share Analysis and Chart

Rhythm Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. It is engaged in the development and commercialization of therapies for patients with rare diseases. The company is focused on its melanocortin-4 receptor (MC4R) agonists, in...

New 52W High in past week

SWOT Analysis

Rhythm Pharmaceuticals Inc. Live Price Chart